F/m Emerald Life Sciences Innovation ETF
LFSC
3 hedge funds and large institutions have $50.2M invested in F/m Emerald Life Sciences Innovation ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
88.82% more ownership
Funds ownership: 2.31% → 91.13% (+89%)
9% more capital invested
Capital invested by funds: $46M → $50.2M (+$4.21M)
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$45.7M |
| 2 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$93.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MASUI
MIRAE ASSET SECURITIES (USA) INC.
New York
|
-$298K |
| 2 |
PFBT
Parkside Financial Bank & Trust
Saint Louis,
Missouri
|
-$27.3K |
LFSC Hedge Fund Activity: Q2 2025 in Review
3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q2 2025, worth a combined $50.2M — up 9.2% from $46M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LFSC and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Emerald Mutual Fund Advisers Trust, opening a new position worth an estimated $45.7M. The largest seller was MIRAE ASSET SECURITIES (USA) INC., exiting entirely with an estimated $298K sold.
- 3 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q2 2025, down from 4 in Q1 2025.
- Funds reported $50.2M of F/m Emerald Life Sciences Innovation ETF stock for Q2 2025, up 9.2% quarter-over-quarter.
- 1 fund opened new F/m Emerald Life Sciences Innovation ETF positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest F/m Emerald Life Sciences Innovation ETF buyer in Q2 2025 was Emerald Mutual Fund Advisers Trust, an estimated $45.7M added.
- The largest F/m Emerald Life Sciences Innovation ETF seller in Q2 2025 was MIRAE ASSET SECURITIES (USA) INC., an estimated $298K sold.
Based on aggregated 13F filings for Q2 2025.